Abiopharma

🔍 Beard, Stephen W. (Executive)

Company: Covista Inc. (CVSA)

Report Date: 2026-06-10

Detailed Transactions and Holdings:

• Sold 2,762 shares of Common Stock at $130.1388 per share (Direct)
  Date: 2026-06-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 426,562.00 | transaction_form_type: 4 | Footnotes: F1, F2, F4
• Sold 2,529 shares of Common Stock at $130.7847 per share (Direct)
  Date: 2026-06-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 424,033.00 | transaction_form_type: 4 | Footnotes: F1, F2, F5

Footnotes:

• F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025 in accordance with Covista's Insider Sales and Ownership Policy Addendum.
• F2: Shares sold represent a portion of holdings in excess of Covista's Stock Ownership and Holding Requirements and were executed in pre-scheduled increments under the trading plan.
• F3: No discretionary trades by the reporting person are permitted under Covista policy; all sales must occur pursuant to a pre-established Rule 10b5-1 trading plan absent a hardship exception.
• F4: This transaction was executed in multiple trades at prices ranging from $130.02 to $130.39. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F5: This transaction was executed in multiple trades at prices ranging from $130.26 to $131.465. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.